• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problems Migration or Expulsion of Device (1395); Human-Device Interface Problem (2949)
Patient Problems Embolism (1829); Transient Ischemic Attack (2109)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, 245 patients were implanted with amplatzer septal occluder and complications during or after the procedure including two patients which had the device embolize, three where the device migrated, eleven patients had a residual shun and four patients had a transient ischemic attack and stroke.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported through a research article identifying amplatzer septal occluders that may be related to a complications post procedure.Details are listed in the article, titled "transcatheter closure vs totally endoscopic robotic surgery for atrial septal defect closure: a single-center experience." between january 2011 and may 2019, amplatzer septal occluders were implanted in 245 patients.The median age was 39, with 180 of them being women.The patients had the following comorbidities: atrial fibrillation, transient ischemic attack (tia), stroke, lung disease, hypertension, coronary artery disease, and diabetes.Complications during and post procedure includes: residual shunt (11), device migration (3), device embolization (2), tia and stroke (4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9850642
MDR Text Key184069440
Report Number2135147-2020-00118
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 03/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/20/2020
Initial Date FDA Received03/18/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age39 YR
-
-